This was a nice article posted over on IHL today and also applies greatly to future targets for IRX.
Now just waiting game for the new BOD and Matthew to finalise trial design and Camargo to submit to FDA.
https://honey.nine.com.au/parenting/cannabis-may-help-relieve-endometriosis-pain-new-australian-study/42f25039-a7e7-4420-8bdc-360afb4c2380
Maybe I need more here too, but think that after last quarterly still have a little bit of time before the train leaves the station in regards to changing from compounding pharmacy to automated GMP manufacturing and then increasing sales growth and international awareness.
But at such a tiny market cap and great Board of Directors leading this, it will be a very interesting next 12 months.
This was a nice article posted over on IHL today and also...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.795M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 400000 | 1 |
View Market Depth
| Last trade - 15.06pm 12/08/2024 (20 minute delay) ? |
| IRX (ASX) Chart |
Day chart unavailable